Key result
TAo-TAVI using the ASCENDRA system poses technical issues requiring specific solutions.
Highlights technical considerations and potential solutions when using the ASCENDRA transapical delivery system for transaortic TAVI.
Answers are grounded in this paper and cite their sources.
Technical issues with ASCENDRA in transaortic TAVI warrant procedural caution; leaves open need for dedicated devices and prospective trials.
Transaortic transcatheter aortic valve implantation (TAo-TAVI) has been recently proposed as an alternative to transapical (TA) and transfemoral (TF) approach. We now discuss a technical issue associated with TAo-TAVI related to the use of a delivery system dedicated to the antegrade TA approach. The potential solutions to this issue as well as the potential advantages of the TAo approach are discussed.
No takes yet. Share an insight, caveat, or question.
Nombela‐Franco et al. (2012) conducted a review in Aortic valve disease. Transaortic transcatheter aortic valve implantation (TAo-TAVI) using ASCENDRA delivery system was evaluated. Transaortic transcatheter aortic valve implantation using the ASCENDRA transapical delivery system is associated with technical issues that require specific solutions.
Synapse has enriched 10 related papers. Consider them for comparative context: